Bottom line
PBE vs PSCT: the short answer
PBE (Invesco Biotechnology & Genome ETF) and PSCT (Invesco S&P SmallCap Information Technology ETF) are quite different portfolios: only about 18% of their top holdings (by weight) are shared.
But PSCT is far broader, holding 73 positions to 33 for PBE, so beyond the top names it adds exposure PBE doesn't have.
PSCT is cheaper at 0.29% vs 0.59% — a difference of $30 a year per $10,000 invested.
Over five years, PSCT returned +8.3% a year vs +3.4% for PBE (reporting dates differ).
Updated Nov 19, 2026
PBE vs PSCT side by side
| PBE | PSCT | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Invesco | Invesco |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.59% | 0.29% |
| Annual cost per $10k | $59 | $29 |
| 10-yr cost on $10k (prospectus) | $738 | $368 |
| Max front load | None | None |
| 12b-1 fee | — | — |
| 1-yr return | +24.7% | −1.1% |
| 5-yr return (annualized) | +3.4% | +8.3% |
| 10-yr return (annualized) | +5.2% | +11.2% |
| Best quarter | +25.3% | +41.6% |
| Worst quarter | −24.3% | −26.1% |
| Net assets (fund) | $281.9M | $541.1M |
| Number of holdings | 33 | 73 |
| Portfolio turnover | 103% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | PBE | PSCT | Difference |
|---|---|---|---|
| 2024 | +1.1% | −1.1% | +2.2% |
| 2023 | +3.7% | +20.7% | −17.0% |
| 2022 | −10.8% | −22.6% | +11.8% |
| 2021 | +1.6% | +26.5% | −25.0% |
| 2020 | +25.5% | +27.5% | −2.0% |
| 2019 | +18.3% | +39.2% | −20.9% |
| 2018 | +0.2% | −9.1% | +9.4% |
| 2017 | +22.4% | +10.1% | +12.3% |
| 2016 | −23.0% | +33.5% | −56.5% |
| 2015 | +2.0% | +4.3% | −2.3% |
Source: Fund prospectus bar charts
Holdings overlap
2 of PBE's top 25 holdings also appear in PSCT's top 25.
| Holding | PBE | PSCT |
|---|---|---|
| Invesco Private Prime Fund | 12.89% | 21.41% |
| Invesco Private Government Fund | 4.97% | 8.21% |
Source: SEC Form N-PORT
PBE top 10
- Invesco Private Prime Fund — 12.89%
- Regeneron Pharmaceuticals, Inc. — 5.47%
- Amgen Inc. — 5.22%
- CareDx, Inc. — 5.04%
- Vertex Pharmaceuticals Inc. — 4.99%
- Invesco Private Government Fund — 4.97%
- Royalty Pharma PLC — 4.94%
- Biogen Inc. — 4.79%
- Gilead Sciences, Inc. — 4.43%
- United Therapeutics Corp. — 4.08%
PSCT top 10
- Invesco Private Prime Fund — 21.41%
- Invesco Private Government Fund — 8.21%
- Sanmina Corp. — 5.29%
- Semtech Corp. — 5.26%
- Viavi Solutions Inc. — 4.19%
- Viasat, Inc. — 4.08%
- FormFactor, Inc. — 3.60%
- Enphase Energy, Inc. — 3.34%
- Qorvo, Inc. — 3.26%
- MaxLinear, Inc. — 2.82%
FAQ
What is the difference between PBE and PSCT?
Which is cheaper, PBE or PSCT?
Should I own both PBE and PSCT?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.